Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Cytomegalovirus Infection

  Free Subscription

Articles published in Clin Transplant

Retrieve available abstracts of 37 articles:
HTML format

Single Articles

    May 2024
  1. SALTIEL G, Faure E, Assaf A, Chopin MC, et al
    Real-life use of letermovir prophylaxis for cytomegalovirus in heart transplant recipients.
    Clin Transplant. 2024;38:e15327.
    PubMed     Abstract available

    April 2024
  2. RAMPERSAD C, Kong W, Wiebe C, Balshaw R, et al
    Safety and efficacy of a reduced frequency viral monitoring strategy for Epstein-Barr virus, cytomegalovirus, and BK polyomavirus post-kidney transplant: A quality assurance initiative.
    Clin Transplant. 2024;38:e15292.
    PubMed     Abstract available

  3. CHIU CY, Mahmood M, Razonable RR, Beam E, et al
    Discordance in serology for cytomegalovirus, Epstein-Barr virus and toxoplasma among thoracic organ donors.
    Clin Transplant. 2024;38:e15301.

  4. CUI J, Zhou Y, Zhao K, Li X, et al
    Application of CMV-IVIg as prophylaxis against cytomegalovirus reactivation in allogeneic hematopoietic stem cell transplantation patients.
    Clin Transplant. 2024;38:e15300.
    PubMed     Abstract available

    March 2024
  5. ROMINE MM, Leeser DB, Kennamer K, Nguyen C, et al
    Early outcomes associated with de novo once-daily extended-release versus twice-daily immediate-release tacrolimus in a predominantly African American kidney transplant population: A single-center observational study.
    Clin Transplant. 2024;38:e15268.
    PubMed     Abstract available

  6. ALAM AH, Van Zyl J, Shakoor HI, Farsakh D, et al
    The impact of active cytomegalovirus infection on donor-derived cell-free DNA testing in heart transplant recipients.
    Clin Transplant. 2024;38:e15287.
    PubMed     Abstract available

    December 2023
  7. ZAIS IE, Sirotti A, Iesari S, Campioli E, et al
    Human cytomegalovirus-related gastrointestinal disease after kidney transplantation: A systematic review.
    Clin Transplant. 2023 Dec 8:e15218. doi: 10.1111/ctr.15218.
    PubMed     Abstract available

    November 2023
  8. SINGH P, Von Stein L, McGowan M, Nolan A, et al
    Comparison of outcomes in vaccinated versus unvaccinated COVID-19 kidney transplant recipients, a single center retrospective study-Is the taboo justified?
    Clin Transplant. 2023 Nov 7:e15187. doi: 10.1111/ctr.15187.
    PubMed     Abstract available

  9. ZHOU X, Zhang S, Fan J, Zhu X, et al
    Risk factors for BK virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis.
    Clin Transplant. 2023;37:e15121.
    PubMed     Abstract available

    October 2023
  10. DIOVERTI MV, Bhaimia E, Yetmar ZA, Melendez DP, et al
    Clinical utility of a cytomegalovirus-specific T cell assay in assessing the risk of post-prophylaxis cytomegalovirus infection and post-treatment relapse.
    Clin Transplant. 2023 Oct 8:e15143. doi: 10.1111/ctr.15143.
    PubMed     Abstract available

    September 2023
  11. JORGENSON MR, Descourouez JL, Saddler CM, Smith JA, et al
    Real world experience with conversion from valganciclovir to letermovir for cytomegalovirus prophylaxis: Letermovir reverses leukopenia and avoids mycophenolate dose reduction.
    Clin Transplant. 2023 Sep 27:e15142. doi: 10.1111/ctr.15142.
    PubMed     Abstract available

    August 2023
  12. SERMET K, Goeminne C, Hantz S, Assaf A, et al
    Reliability of QuantiFERON(R)-CMV in predicting CMV recurrence in heart transplant recipients: A single-center retrospective study.
    Clin Transplant. 2023 Aug 29:e15109. doi: 10.1111/ctr.15109.
    PubMed     Abstract available

    July 2023
  13. LERMAN JB, Green CL, Molina MR, Maharaj V, et al
    Multicenter study of universal prophylaxis versus pre-emptive therapy for patients at intermediate risk (R+) for CMV following heart transplantation.
    Clin Transplant. 2023 Jul 1:e15065. doi: 10.1111/ctr.15065.
    PubMed     Abstract available

    May 2023
  14. KREISER ML, Dupuis R, Szempruch KR, Chargualaf LM, et al
    Reduced dosing versus full dosing valganciclovir for prophylaxis of cytomegalovirus in high-risk abdominal transplant recipients.
    Clin Transplant. 2023 May 31:e15041. doi: 10.1111/ctr.15041.
    PubMed     Abstract available

    March 2023
  15. GARDINER BJ, Bailey JP, Percival MA, Morgan BA, et al
    Incidence and severity of cytomegalovirus infection in seropositive heart transplant recipients.
    Clin Transplant. 2023 Mar 29:e14982. doi: 10.1111/ctr.14982.
    PubMed     Abstract available

  16. ZONA E, Jorgenson M, Dolma S, Santos A, et al
    Discordance in cytomegalovirus viremia in kidney recipients from the same donor is associated with the worst outcomes.
    Clin Transplant. 2023 Mar 26:e14979. doi: 10.1111/ctr.14979.
    PubMed     Abstract available

    February 2023
  17. SABATINO DC, Hedvat J, Salerno DM, Pereira MR, et al
    Real world experience with maribavir for the treatment of cytomegalovirus in solid organ transplant recipients.
    Clin Transplant. 2023 Feb 5:e14929. doi: 10.1111/ctr.14929.

    January 2023
  18. PEDNEKAR P, Graf M, Tuly R, Batt K, et al
    Gaining consensus around patient risk groups and prognostic profiles to guide CMV management among patients with solid organ transplant: insights from a Delphi panel with SOT experts.
    Clin Transplant. 2023 Jan 5:e14905. doi: 10.1111/ctr.14905.
    PubMed     Abstract available

    November 2022
  19. VAN AELST LNL, Droogne W, Voros G, Van Cleemput J, et al
    Combination Prophylaxis in CMV high risk heart transplant recipients - a single centre experience.
    Clin Transplant. 2022 Nov 14:e14848. doi: 10.1111/ctr.14848.
    PubMed     Abstract available

  20. JORGENSON MR, Kleiboeker HL, Astor BC, Gentry AC, et al
    Seasonal variation of cytomegalovirus disease in kidney transplant recipients.
    Clin Transplant. 2022 Nov 10:e14852. doi: 10.1111/ctr.14852.
    PubMed     Abstract available

    October 2022
  21. ZANG S, Zhang X, Niu J, Das BB, et al
    Impact of induction therapy on cytomegalovirus infection and post-transplant outcomes in pediatric heart transplant recipients receiving routine antiviral prophylaxis.
    Clin Transplant. 2022 Oct 19:e14836. doi: 10.1111/ctr.14836.
    PubMed     Abstract available

    September 2022
  22. GOLOB S, Batra J, DeFilippis EM, Uriel M, et al
    Letermovir for Cytomegalovirus Prophylaxis in High Risk Heart Transplant Recipients.
    Clin Transplant. 2022 Sep 10:e14808. doi: 10.1111/ctr.14808.
    PubMed     Abstract available

    March 2022
  23. HIDAKA Y, Goto N, Yamanaga S, Kinoshita K, et al
    Two-year outcomes of low-exposure extended-release tacrolimus and mycophenolate mofetil regimen in de novo kidney transplantation: A multi-center randomized controlled trial.
    Clin Transplant. 2022 Mar 28:e14655. doi: 10.1111/ctr.14655.
    PubMed     Abstract available

  24. CAMPOS-VARELA I, Blumberg EA, Giorgio P, Kotton CN, et al
    What is the optimal antimicrobial prophylaxis to prevent postoperative infectious complications after liver transplantation? - A systematic review of the literature and expert panel recommendations.
    Clin Transplant. 2022 Mar 8:e14631. doi: 10.1111/ctr.14631.
    PubMed     Abstract available

  25. NGUYEN A, Finci L, Berney T, Tonoli D, et al
    Letermovir for cytomegalovirus primary prophylaxis in a multiple abdominal/ small bowel transplant recipient.
    Clin Transplant. 2022 Mar 2:e14624. doi: 10.1111/ctr.14624.

    January 2022
  26. MEHTA RB, Shimko K, Zhang X, Puttarajappa C, et al
    Rabbit antithymocyte globulin dose and early subclinical and clinical rejections in kidney transplantation.
    Clin Transplant. 2022 Jan 9:e14582. doi: 10.1111/ctr.14582.
    PubMed     Abstract available

  27. BRAR S, Berry R, Raval AD, Tang Y, et al
    Outcomes among CMV-mismatched and highly sensitized kidney transplants recipients who develop neutropenia.
    Clin Transplant. 2022 Jan 4:e14583. doi: 10.1111/ctr.14583.
    PubMed     Abstract available

    December 2021
  28. AFZAL A, Alam A, van Zyl JS, Zafar H, et al
    Observed Elevated Donor-Derived Cell Free DNA in Orthotopic Heart Transplant Recipients Without Clinical Evidence of Rejection.
    Clin Transplant. 2021 Dec 4:e14549. doi: 10.1111/ctr.14549.
    PubMed     Abstract available

    November 2021
  29. ORTIZ F, Lempinen M, Aaltonen S, Koivuviita N, et al
    Letermovir treatment for CMV infection in kidney and pancreas transplantation: a valuable option for complicated cases.
    Clin Transplant. 2021 Nov 19:e14537. doi: 10.1111/ctr.14537.
    PubMed     Abstract available

    July 2021
  30. JORGENSON MR, Descourouez JL, Leverson GE, Saddler CM, et al
    A Pilot Study of an Intensified Ganciclovir Dosing Strategy for Treatment of Cytomegalovirus Disease in Kidney and/or Pancreas Transplant Recipients.
    Clin Transplant. 2021 Jul 15. doi: 10.1111/ctr.14427.
    PubMed     Abstract available

    June 2021
  31. RHO E, Naf B, Tf M, Rp W, et al
    Use of Letermovir-Valganciclovir combination as a step-down treatment after Foscarnet for Ganciclovir-resistant CMV infection in kidney transplant recipients.
    Clin Transplant. 2021 Jun 28. doi: 10.1111/ctr.14401.
    PubMed     Abstract available

  32. JORGENSON MR, Marka N, Leverson GE, Smith JA, et al
    Valganciclovir Prophylaxis Extension from 3 to 6 Months in High Risk Pancreas Transplant Recipients Does Not Impact Incidence of Cytomegalovirus Infection at 12 months.
    Clin Transplant. 2021 Jun 2:e14379. doi: 10.1111/ctr.14379.
    PubMed     Abstract available

    May 2021
  33. DURST MM, Jorgenson MR, Descourouez JL, Saddler CM, et al
    Bimonthly viral monitoring for late-onset cytomegalovirus infection-Balancing efficacy with patient palatability; A reply to Melgarejo et al.
    Clin Transplant. 2021 May 21:e14348. doi: 10.1111/ctr.14348.

    March 2021
  34. VEIT T, Pan M, Munker D, Arnold P, et al
    Association of CMV-specific-T-cell immunity and risk of CMV infection in lung transplant recipients.
    Clin Transplant. 2021 Mar 22:e14294. doi: 10.1111/ctr.14294.
    PubMed     Abstract available

  35. RAHIMISHAHMIRZADI M, Jevnikar AM, House AA, Luke PP, et al
    Late-onset Allograft Rejection, Cytomegalovirus Infection and Renal Allograft Loss: Is Anti-CMV Prophylaxis Required Following Late-onset Allograft Rejection?
    Clin Transplant. 2021 Mar 13:e14285. doi: 10.1111/ctr.14285.
    PubMed     Abstract available

    February 2021
  36. MELGAREJO I, Jorgensen D, Hariharan S, Puttarajappa CM, et al
    Bimonthly Viral Monitoring for Late-Onset Cytomegalovirus infection in Kidney Transplant Recipients.
    Clin Transplant. 2021 Feb 19:e14259. doi: 10.1111/ctr.14259.
    PubMed     Abstract available

    January 2021
  37. VON STEIN L, Leino AD, Pesavento T, Rajab A, et al
    Antithymocyte induction dosing and incidence of opportunistic viral infections using steroid-free maintenance immunosuppression.
    Clin Transplant. 2021;35:e14102.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cytomegalovirus Infection is free of charge.